 Adenosine-5'-(N-ethylcarboxamide)
"Adenosine-5'-(N-ethylcarboxamide)" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A stable adenosine A1 and A2 receptor agonist. Experimentally, it inhibits cAMP and cGMP phosphodiesterase activity.
| Descriptor ID |
D019830
|
| MeSH Number(s) |
D03.633.100.759.590.138.025 D13.570.583.138.025 D13.570.800.096.250
|
| Concept/Terms |
Adenosine-5'-(N-ethylcarboxamide)- Adenosine-5'-(N-ethylcarboxamide)
- N6-Ethyl-carboxamido Adenosine
- Adenosine, N6-Ethyl-carboxamido
- N6 Ethyl carboxamido Adenosine
- NECA
- Adenosine-5'-N-ethyluronamide
- Adenosine 5' N ethyluronamide
- 5'-N-Ethylcarboxamidoadenosine
- 5' N Ethylcarboxamidoadenosine
- N-Ethylcarboxamidoadenosine
- N Ethylcarboxamidoadenosine
|
Below are MeSH descriptors whose meaning is more general than "Adenosine-5'-(N-ethylcarboxamide)".
Below are MeSH descriptors whose meaning is more specific than "Adenosine-5'-(N-ethylcarboxamide)".
This graph shows the total number of publications written about "Adenosine-5'-(N-ethylcarboxamide)" by people in this website by year, and whether "Adenosine-5'-(N-ethylcarboxamide)" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 | | 1995 | 0 | 1 | 1 | | 2002 | 0 | 1 | 1 | | 2009 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Adenosine-5'-(N-ethylcarboxamide)" by people in Profiles.
-
Ehrentraut H, Westrich JA, Eltzschig HK, Clambey ET. Adora2b adenosine receptor engagement enhances regulatory T cell abundance during endotoxin-induced pulmonary inflammation. PLoS One. 2012; 7(2):e32416.
-
Liu Q, Li J, Khoury J, Colgan SP, Ibla JC. Adenosine signaling mediates SUMO-1 modification of IkappaBalpha during hypoxia and reoxygenation. J Biol Chem. 2009 May 15; 284(20):13686-13695.
-
Comerford KM, Lawrence DW, Synnestvedt K, Levi BP, Colgan SP. Role of vasodilator-stimulated phosphoprotein in PKA-induced changes in endothelial junctional permeability. FASEB J. 2002 Apr; 16(6):583-5.
-
Dreskin SC. ATP-dependent activation of phospholipase C by antigen, NECA, Na3VO4, and GTP-gamma-S in permeabilized RBL cell ghosts: differential augmentation by ATP, phosphoenolpyruvate and phosphocreatine. Mol Cell Biochem. 1995 May 24; 146(2):165-70.
-
Mynlieff M, Beam KG. Adenosine acting at an A1 receptor decreases N-type calcium current in mouse motoneurons. J Neurosci. 1994 Jun; 14(6):3628-34.
-
Hershberger RE, Feldman AM, Bristow MR. A1-adenosine receptor inhibition of adenylate cyclase in failing and nonfailing human ventricular myocardium. Circulation. 1991 Apr; 83(4):1343-51.
-
Zolnierowicz S, Work C, Hutchison K, Fox IH. Partial separation of platelet and placental adenosine receptors from adenosine A2-like binding protein. Mol Pharmacol. 1990 Apr; 37(4):554-9.
-
Elphick M, Taghavi Z, Powell T, Godfrey PP. Chronic carbamazepine down-regulates adenosine A2 receptors: studies with the putative selective adenosine antagonists PD115,199 and PD116,948. Psychopharmacology (Berl). 1990; 100(4):522-9.
-
Work C, Hutchison K, Prasad M, Bruns RF, Fox IH. Characteristics of an adenosine A1 binding site in human placental membranes. Arch Biochem Biophys. 1989 Jan; 268(1):191-202.
-
Ukena D, Poeschla E, H?ttemann E, Schwabe U. Effects of N-ethylmaleimide on adenosine receptors of rat fat cells and human platelets. Naunyn Schmiedebergs Arch Pharmacol. 1984 Sep; 327(3):247-53.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|